Accelerating Innovation & Access in Global Health Technologies

The latest progress in the fight against infectious diseases


The conference, co-hosted by Mitsubishi UFJ Research and Consulting (MURC), Foundation for Innovative New Diagnostics (FIND), Global Health Innovative Technology Fund (GHIT), International AIDS Vaccine Initiative (IAVI), and Coalition for Epidemic Preparedness Innovation (CEPI), brought together experts in preventive health technologies, such as surveillance, diagnostics, and vaccines, to discuss the latest innovations as well as ways to increase access through improvements in regulatory, registration, and delivery aspects of new medical products. The conference’s four sessions focused on key topics in diagnostics, surveillance, vaccines, and access and delivery.
My therapist always says that in any case, you can not tolerate a headache. I work as an accountant, and sometimes you can research a pile of documents for a day, counting and reducing debit to credit. I often have a headache and I immediately take Tramadol, it relieves pain, normalizes slightly elevated blood pressure. There is more information on the website

Date: 25 February 2019, Tokyo, Japan. Venue: Mitsubishi UFJ Research and Consulting (Tokyo Office), Seminar Room in 24th Floor

Opening | 9:00 am – 9:25 am

Welcome: Representative from Mitsubishi UFJ Research and Consulting
Opening remarks: Prof. David Heymann, Head and Senior Fellow, Center on Global Health Security, Chatham House

(Session 1) The latest diagnostic technologies: point-of-care/rapid testing | 9:25 am–11:05 am
Panelists will discuss the latest trends and challenges in diagnostics and future directions, focusing on POCT/rapid tests. Moderator: Ranald Sutherland, Consultant for Technology and Business Development, FIND

Christian Becker, Vice President Sales, HUMAN
Osamu Kunii, Head, Strategy, Investment and Impact Division, The Global Fund to Fight AIDS, Tuberculosis and Malaria
Javan Esfandiari, CTO, Chembio
Atsuo Suga, General Manager, Global Business, TAUNS Laboratories
Khuất Thị Hải Oanh, Executive Director, Centre for Supporting Community Development Initiatives, Vietnam

(Session 2) The advent of new technologies and their contribution to global health surveillance | 11:05 am–12:45 pm
Panelists will discuss artificial intelligence, drones, and communications technologies, which have the potential to contribute to the management of infectious diseases. Moderator: Michikazu Koshiba, Head, Center on Global Health Architecture, Mitsubishi UFJ Research & Consulting

Helmi Zakariah, CEO, AIME
Afif Bahardin, the State Health Minister, Penang State Gov, Malaysia
Guido Geerts, CEO, Delft Imaging Systems
Eri Machii, CEO, AfriMedico
Isabelle Buckle, Executive Vice President, Technology Transfer & Industrial Partnerships, Institut Pasteur

Lunch break | 12:45 pm – 13:45 pm

(Session 3) The latest innovations in vaccine research and development | 13:45 pm–15:25 pm
Panelists will discuss the latest scientific advancement, as well as new partnerships and models of collaboration. Moderator: Anita Kawatra, Vice President, Communications, International AIDS Vaccine Initiative

Frederik Kristensen, Deputy CEO, Coalition for Epidemic Preparedness Innovation
Mark Feinberg, President & CEO, International AIDS Vaccine Initiative
Gaudensia Mutua, Clinical Trials Team Leader, KAVI-Institute of Clinical Research, University of Nairobi
Rajeev Venkayya, President, Global Vaccine Business Unit, Takeda Pharmaceutical

(Session 4) Ensuring access and delivery in low- and middle-income countries | 15:25 pm–17:05 pm
Panelists will discuss the factors that ensure access to new technologies in LMICs. Moderator: Hayato Urabe, Director, Investment Strategy, Planning & Management, GHIT

Rosanna Peeling, Professor & Chair of Diagnostics Research, Director of the International Diagnostics Centre, LSHTM
Naofumi Hashimoto, Clinical Technologist, National Center on Global Health and Medicine
Bryan Richmond, Regional Director for East & South Africa, Crown Agents Limited
Seth Berkley, CEO, Gavi (invited)
Teruo Takahashi, Manager, In Vitro Diagnostics Division, Medical Systems Business Division, FUJIFILM Corporation


Conference website